Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...

The ‘4S’ Pathway was designed to guide shifting needs in older adults with diabetes who are struggling with diabetes ...

Ascletis is taking a low and slow approach to oral GLP-1 dose titration in a phase 2a test after getting a look at clinical ...

Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!

Shares of Eli Lilly (LLY) jumped on Thursday morning after the company announced topline Phase 3 results from ACHIEVE-1, evaluating the safety ...

Counterfeit forms of weight loss and diabetes drugs are endangering consumers, and Oklahoma General Attorney Gentner Drummond wants to take action against what he calls "bad actors" in the ...

But it is an oral version of the GLP-1 analogue that holds the greatest promise for patients with diabetes - and for the company's revenues. Phase 3 trials of injectable semaglutide have shown it ...

Originally developed for diabetes management, these drugs were later found to have profound weight-loss effects. Among them, semaglutide (sold as Ozempic and Wegovy) and tirzepatide (sold as ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply ... Half of the participants got a weekly shot of semaglutide, the drug in Ozempic and Wegovy ...

For diabetes management, we already have oral semaglutide, Rybelsus, available in the market. While Ozempic is designed specifically for diabetes treatment, Wegovy addresses the unique needs of ...

Although only association and not causality can be inferred, this study showed that, among patients who had diabetes, an elevated risk of NAION was associated with semaglutide use compared with ...

Compounded semaglutide and Ozempic are different products. While both may be used in people with type 2 diabetes, Ozempic is approved by the FDA, but compounded semaglutide is not. Compounded ...